MiR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6

Yunhe An,Jun Zhang,Baoming Li,Yanjie Tian,Xiaoli Zhang,Fangqi Zhao,Xiaoyan Cheng

doi:10.1186/s12935-020-01300-0

Yunhe An, Jun Zhang + Show 5 more

Open Access

https://doi.org/10.1186/s12935-020-01300-0

Copy DOI

Abstract

BackgroundThe aberrant expression of microRNA-454 (miR-454) has been confirmed to be involved in the development of cancers. However, the functional role of miR-454 in the progression of ovarian cancer remains unclear.MethodsThe expression of miR-454 in ovarian cancer cells and serum of ovarian cancer patients was detected by RT-PCR. CCK8, colony formation, transwell, and flow cytometry assays were conducted to assess the effects of miR-454 on ovarian cancer cell proliferation, migration, invasion, and apoptosis, respectively. Dual-luciferase reporter assay was used to confirm the targeting relationship between miR-454 and E2F6. The expression pattern of E2F6 in ovarian cancer tissues was detected using immunohistochemistry (IHC) assay. The relative expression of related proteins was examined using western blot analysis.ResultsmiR-454 was markedly down-regulated by hypoxia in ovarian cancer cells. Compared with normal samples, the expression of miR-454 was up-regulated in the serum of ovarian cancer patients, and correlated with the clinicopathological stages of ovarian cancer. Next, we found that miR-454 overexpression inhibited the proliferation, migration and invasion of OVCAR3 and SKOV3 cells, as well as promoted apoptosis. In addition, the Akt/mTOR and Wnt/β-catenin signaling pathway were inhibited by miR-454 in ovarian cancer cells. Mechanically, bioinformatic analysis and dual-luciferase reporter assay confirmed that E2F6 was a direct target of miR-454 and negatively regulated by miR-454 in ovarian cancer cells. Moreover, IHC analysis showed that E2F6 was highly expressed in ovarian cancer tissues. Finally, we found that the increasing cell proliferation and migration triggered by E2F6 overexpression were abolished by miR-454 overexpression.ConclusionTaken together, these results highlight the role of miR-454 as a tumor suppressor in ovarian cancer cells by targeting E2F6, indicating that miR-454 may be a potential diagnostic biomarker and therapeutic target for ovarian cancer.

Highlights

The aberrant expression of microRNA-454 has been confirmed to be involved in the development of cancers
Results miR‐454 is up‐regulated in ovarian cancer and suppresses the proliferation, migration and invasion of ovarian cancer cells To investigate whether miR-454 is correlated to the progression of ovarian cancer, we first examined the expression of miR-454 in ovarian cancer
To elucidate the functional role of miR-454 in ovarian cancer, pCMV-MIR-miR-454 was transfected into ovarian cancer cell lines OVCAR3 and SKOV3, pCMV-MIR plasmid was used as negative control (NC)

Summary

Introduction

The aberrant expression of microRNA-454 (miR-454) has been confirmed to be involved in the development of cancers. The functional role of miR-454 in the progression of ovarian cancer remains unclear. Increasing number of studies reveal that microRNAs (miRNAs) are closely involved in tumorigenesis and tumor progression [8,9,10]. MiR-454 has been reported to be implicated in the progression of many types of cancer, playing dual roles in different tumors. Studies show that miR-454 functions as an oncogene in colorectal cancer [17], hepatocellular carcinoma [18] and non-small cell lung cancer [19], but servers as a tumor suppressor in osteosarcoma [20] and glioblastoma [21]. The function and mechanism of miR-454 in ovarian cancer remain largely unclear

Methods

Results

Discussion

Conclusion